Lisheng Pharmaceutical: Adenine phosphate raw materials approved for market application.

Lisheng Pharmaceutical announced that the company has received the approval notification for the market application of adenosine 5'-monophosphate, a chemical raw material medicine, issued by the National Medical Products Administration. This product, formerly known as Vitamin B4, is involved in the synthesis of DNA and RNA in the body and is clinically used to prevent and treat leukopenia. The approval of this product is beneficial for the company to form industrial synergy with its formulation products and enhance market competitiveness.